Fueled by its bold commitment to sustainability and a net-zero future, this global pharmaceutical organization set out to reinvent its fleet operations. In 2024, several years after launching their Global Green Fleet strategy, U.S. EV adoption achieved approximately 25%. Aligned to an updated Global Fleet Strategy, committed to eliminating fleet emissions, they partnered with Wheels to advance progress. What followed was a strategic pivot that reimagined the fleet experience and laid the groundwork for meaningful, measurable change.\r\n\r\n<\/p>\r\n
The strategy came to life in early 2025 with a dynamic, multi-pronged initiative designed to put drivers in the driver\u2019s seat \u2013 literally and figuratively. At its core was the launch of the company\u2019s Choice program, giving drivers the freedom to select either a company-leased vehicle focused on EV choices or reimbursement through a newly introduced Fixed and Variable Reimbursement (FAVR) model. For consistent emphasis on sustainability, they included an incentive for any driver enrolling an EV in the FAVR program.\r\n\r\n<\/p>\r\n
The fleet policy was updated to reflect the new flexibility, and Wheels supported the rollout with multiple educational sessions in early 2025, ensuring drivers were equipped with the knowledge to make confident, informed decisions.\r\n\r\n<\/p>\r\n
The impact was confirmed before the Choice program was in place for a full year. The organization had risen past its previous plateau, with the EV adoption reaching 34%. The FAVR program also saw strong momentum, with over 120 drivers enrolled in the first six months. Even more exciting, about 20% of them have chosen EVs, proof that the incentive is driving sustainable choices.\r\n\r\n<\/p>\r\n
This initiative didn\u2019t just move the needle; it redefined what\u2019s possible when innovation, collaboration, and purpose come together. With a clear path to net-zero, this client sets a powerful example.<\/p>\r\n
<\/p>","protected":false},"excerpt":{"rendered":"
Fueled by its bold commitment to sustainability and a net-zero future, this global pharmaceutical organization set out to reinvent its fleet operations. In 2024, several years after launching their Global Green Fleet strategy, U.S. EV adoption achieved approximately 25%. Aligned to an updated Global Fleet Strategy, committed to eliminating fleet emissions, they partnered with Wheels […]<\/p>\n","protected":false},"author":87,"featured_media":25981044,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"project_category":[24],"project_tag":[],"class_list":["post-25980753","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-success-stories","topics-customer-success","topics-electric-vehicles","topics-sustainability"],"acf":[],"yoast_head":"\n